|
National Award and
Research Grant Program
The Susan
G. Komen for the Cure Award and Research Grant Program
supports innovative breast cancer research and a variety
of meritorious awards and educational and scientific
programs around the world. Since its inception in 1982,
Komen has awarded more than 850 grants totaling more
than $110 million for breast cancer research.
Oftentimes, the Komen Foundation is the only source of
funding for cutting-edge breast cancer research, some of
which has led to landmark discoveries in the quest to
find a cure for and eventually prevent breast cancer.
Credited with bringing a new level of integrity to the
grant application and review process, Komen adheres to a
peer review process that is recognized by the National
Cancer Institute (NCI). In the case of basic, clinical
and translational research grants, applications are
reviewed through a blind, or anonymous, peer-review
process. The current program includes:
-
Training grants to
doctoral dissertation students and postdoctoral
fellows to recruit and retain young scientists
in the field of breast cancer research;
-
Basic, clinical
and translational grants that encompass a broad
number of focus areas including detection,
diagnosis, prognosis, risk, prevention,
treatment, tumor cell biology, and complementary
and alternative therapies;
-
Imaging technology
research to improve breast cancer screening and
diagnosis; and
Epidemiological research to address the disparities that
exist in breast cancer incidence and mortality rates
among specific populations. In addition to funding
research grants and educational and scientific programs,
the Foundation supports a meritorious award program that
includes Komen's Brinker Award for Scientific
Distinction, the Komen Scholarship Program, Komen
Interdisciplinary Fellowships and the Komen Professor of
Survivorship Awards. |
